In-Silico Investigation of the Anti-Ulcer Potentials of Ethanolic Extract of Chromolaena Odarata
DOI:
https://doi.org/10.59890/ijels.v2i2.969Keywords:
Omeprazole, Gastric Pump, Ulcer, In-Silico, InhibotoryAbstract
Chromolaena odorata popularly called devil weed (in dependent leaves) is a subtropical flowering shrub in the family of Asteraceae that has been used for the herbal treatment of wounds, burns, skin infections, and relieving painful stomach ulcers. There are some scientific literature reporting its antimicrobial, wound healing, hemostatic, antioxidant, anti-inflammatory, platelet protective, anticancer, hypoglycemic, hypolipidemic, insecticidal, and anti-anemic properties. This study investigated the phytochemical components and the anti-ulcer (gastric pump inhibition) properties of the ethanolic extract of the plant using GC-MS and in silico molecular docking. The GC-MS results from this study detected thirty (30) retentions with fifty-one (51) library/ID-suggested compounds. The docking of the detected compounds against gastric proton pump for the treatment of ulcer revealed that among the ligands that were docked with the enzyme (H+/K+-ATPase); (3-(Azepan-1-yl)-1,2-benzothiazole 1,1-dioxide) had better binding energy value (high binding energy value) (-8.4kcal/mol) compared to the standard anti-ulcer drug (omeprazole; −8.0 kcal/mol). The strong bonding of 3-(Azepan-1-yl)-1,2 benzothiazole 1,1-dioxide to the receptor suggests that the compound may possess better gastric proton pump inhibitory potential than omeprazole. This result may also validate the traditional use of the plant for gastric ulcer-relieving activity.
References
Nesom, Guy L. (2006). "Chromolaena odorata". In Flora of North America Editorial Committee (ed.). Flora of North America North of Mexico (FNA). Vol. 21
Femi Olawale, Kolawole Olofinsan and Opeyemi Iwaloye (2022), Biological activities of Chromolaena odorata: A mechanistic review. South African Journalof BotanyVolume 144 P 44-57
Vu, L. D., Nguyen, H. T., Le, D. H., Nguyen, M. T., & Nguyen, T. X. (2023). Anti-Ulcer Effect on Indomethacin-Induced Ulcerated Mice of Chromolaena odorata Leaf from Vietnam and its Secondary Metabolites: http://www.doi.org/10.26538/tjnpr/v7i5.8. Tropical Journal of Natural Product Research (TJNPR), 7(5), 2889–2894.
Meutia Zahara (2019) Description of Chromolaena odorata L. IOP Conf. Ser.: Mater. Sci. Eng. 506 01202
Tonzibo Z F, Wognin E, Chalchat J C, and Guessan Y T N (2007) “Chemical investigations of Chromolaena odorata L. King Robinson from Ivory Coast”. Journal of essential oils –Bearing Plants 10 (2) pp. 94-100
N Nwinuka, B Nwiloh and J Eresama (2009) “Nutritional and potential medicinal value of chromolaena odorata leaves” International Journal of Tropical
Samuel O Onojam Gladys C Ezeh, Nkeiruka E Udeh, Chinyere B C Ikpa, Daniel Ngozi et al (2021) “Anti-ulcer property of ethanolic fraction of Callichilia subsessilis leaf extract in albino rat” Nortulae Scientia Biologicae 13(1)
Papatheodoridis GV & Archimandritis AJ. (2005) “Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users”. World J. Gastroenterol. ;11:3811–3816
Khalid Bin Abbas (2023) “The Major Causes of Peptic Ulcer Disease (PUD) and its Diagnosis J. of clinical gastr0enterology and hepatology” Short Communication - Volume 7, Issue 1
Sonnenberg A, Everhart JE. The prevalence of self-reported peptic ulcer in the United States. Am J Public Health. 1996;86:200–205. [PMC free article] [PubMed] [Google Scholar]
Ramakrishnan K, Salinas RC. (2007) “Peptic ulcer disease”. Am Fam Physician. ;76:1005–1012.
Magalhães Queiroz DM, Luzza F. (2006) “Epidemiology of helicobacter pylori infection. Helicobacter”;11(suppl 1):1–5.
Delport W., van der Merwe SW. (2007) “The transmission of Helicobacter pylori: The effects of analysis method and study population on inference”. Best Pract Res Clin Gastroenterol.;21(2):215–236.
Papatheodoridis GV, Archimandritis AJ. (20050 “Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users”. World J Gastroenterol. ;11:3811–3816.
“Talia F. Malik; Karthik Gnanapandithan; Kevin Singh. (2023) “Peptic Ulcer Disease” National Library of medicine. StatPearls PublishingTreasure Island (FL):
Narayanan M, Reddy KM, Marsicano E. (2018) “Peptic Ulcer Disease and Helicobacter pylori infection”. Mo Med. May-Jun;115(3):219-224
Arkkila PE, Seppälä K, Kosunen TU. (2005) “Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers”. Eur J Gastroenterol Hepatol.;17(1):93–101.
Fallone CA, Moss SF, Malfertheiner P. (2019) “Reconciliation of recent Helicobacter pylori treatment guidelines in a time of increasing resistance to antibiotics”. Gastroenterology.;157(1):44–53.
Libo Wang, Jianguang Zhang, Meilian Hu, and Xiaoli Pang (2021) “Comparison of Drug Resistance of Helicobacter pylori Between Children and Adults in Jilin”, ChinaTurk J Gastroenterol. 32(12): 1012–1018.
Somasundaram S, Sigthorsson G, Simpson RJ, Watts J, Jacob M, Tavares IA, et al (2000). “Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat”. Aliment Pharmacol Ther. ;14:639–650
Lanas A & Chan FKL. (2017) “Peptic ulcer disease”. The Lancet. ;390:613–624.
Lanas Á, Carrera-Lasfuentes P, Arguedas Y, García S, Bujanda L, Calvet X, Ponce J, Perez-Aísa Á, Castro M, Muñoz M, Sostres C, García-Rodríguez LA. (2015) “Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants”. Clin Gastroenterol Hepatol. ;13(5):906-12.
Huang JQ, Sridhar S, Hunt RH. (2002) “Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis”. Lancet. 05;359(9300):14-22.
Sharifi-Rad, M., Fokou, P. V. T., Sharopov, F., Martorell, M., Ademiluyi, A. O., Rajkovic, J., ... & Sharifi-Rad, J. (2018). “Antiulcer agents: From plant extracts to phytochemicals in healing promotion”. Molecules, 23(7), 1751.& Nworu, C. S. (2020). “Evaluation of the Antiulcer Activity of Methanol/Methylene Chloride Leaf Extract of Chromolaena odorata (L.) in Rats”. Trends Nad. Prod. Res, 1(2), 87-98.
Vu, L. D., Nguyen, H. T., Le, D. H., Nguyen, M. T., & Nguyen, T. X. (2023). “Anti-Ulcer Effect on Indomethacin-Induced Ulcerated Mice of Chromolaena odorata Leaf from Vietnam and its Secondary Metabolites”. Tropical Journal of Natural Product Research, 7(5).
Ikpa CCB and Maduka TOD. (2020) "Antimicrobial Properties of Methanol Extract of Dacryodes edulis Seed and Determination of Phytochemical Composition Using FTIR and GCMS." Chem Afr.; 3(4):927-935
Chinyere B.C. Ikpa, Ujupaul J.M. Ikezu , Maryjoy C. Maduwuba (2022), “In Silico Docking Analysis of Anti-malaria and Anti-typhoid Potentials of Phytochemical Constituents of Ethanol Extract of Dryopteris dilatata” Trop J Nat Prod Res, 6(5):772-782
Duru IA and Duru CE. (2019) “Identification and quantification of phytochemicals from Carica papaya Linn (Caricaceae) root extract using GC-FID”. J Chem Soc Nigeria.; 44(7):1291-1297.
The Ikpa Chinyere Benardette Chinaka , Maduka Tochukwu Oluwatosin , Ikezu, Ujupaul, Adindu, Blessing , Ugariogu Sylvester (2023) “Insilico Molecular Docking of the Compounds of the Crude Extract of Dacryodes Edulis Leaves Against Alpha Enolase to Assess Its Activities on the Treatment of Bacterial Pneumonia” IRE Journals 7 (1) 2456-8880
Trott, O. and Olson, A.J. (2010) “AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading”. Journal of Computational Chemistry, 31, 455-461
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Chinyere B C Ikpa
This work is licensed under a Creative Commons Attribution 4.0 International License.
